BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11737987)

  • 21. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity.
    Guo LQ; Taniguchi M; Xiao YQ; Baba K; Ohta T; Yamazoe Y
    Jpn J Pharmacol; 2000 Feb; 82(2):122-9. PubMed ID: 10877530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro inhibition of midazolam and quinidine metabolism by flavonoids.
    Ha HR; Chen J; Leuenberger PM; Freiburghaus AU; Follath F
    Eur J Clin Pharmacol; 1995; 48(5):367-71. PubMed ID: 8641324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ; Madan A; Parkinson A
    Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4.
    Row EC; Brown SA; Stachulski AV; Lennard MS
    Org Biomol Chem; 2006 Apr; 4(8):1604-10. PubMed ID: 16604230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
    Paine MF; Criss AB; Watkins PB
    Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.
    Guo LQ; Yamazoe Y
    Acta Pharmacol Sin; 2004 Feb; 25(2):129-36. PubMed ID: 14769198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.
    Fukuda K; Ohta T; Oshima Y; Ohashi N; Yoshikawa M; Yamazoe Y
    Pharmacogenetics; 1997 Oct; 7(5):391-6. PubMed ID: 9352575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of novel furanocoumarin dimers as potent and selective inhibitors of CYP3A4.
    Row E; Brown SA; Stachulski AV; Lennard MS
    Drug Metab Dispos; 2006 Feb; 34(2):324-30. PubMed ID: 16299162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New grapefruit cultivars exhibit low cytochrome P4503A4-Inhibition activity.
    Guttman Y; Yedidia I; Nudel A; Zhmykhova Y; Kerem Z; Carmi N
    Food Chem Toxicol; 2020 Mar; 137():111135. PubMed ID: 31968226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of Furanocoumarin, Benzofuran and Coumarin Derivatives Possessing an Inhibitory Effect on Human CYP, and Elucidation of the Inhibitory Mechanism].
    Yamaguchi Y
    Yakugaku Zasshi; 2017; 137(10):1209-1214. PubMed ID: 28966261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition.
    Paine MF; Criss AB; Watkins PB
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1151-60. PubMed ID: 15485894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4.
    Row EC; Brown SA; Stachulski AV; Lennard MS
    Bioorg Med Chem; 2006 Jun; 14(11):3865-71. PubMed ID: 16481174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit.
    Girennavar B; Jayaprakasha GK; Jadegoud Y; Nagana Gowda GA; Patil BS
    Bioorg Med Chem; 2007 Jun; 15(11):3684-91. PubMed ID: 17400460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.
    Edwards DJ; Bellevue FH; Woster PM
    Drug Metab Dispos; 1996 Dec; 24(12):1287-90. PubMed ID: 8971132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The character of inhibition of the metabolism of 1,2-benzopyrone (coumarin) by grapefruit juice in human.
    Runkel M; Bourian M; Tegtmeier M; Legrum W
    Eur J Clin Pharmacol; 1997; 53(3-4):265-9. PubMed ID: 9476043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.
    So FV; Guthrie N; Chambers AF; Moussa M; Carroll KK
    Nutr Cancer; 1996; 26(2):167-81. PubMed ID: 8875554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.
    Fuhr U; Klittich K; Staib AH
    Br J Clin Pharmacol; 1993 Apr; 35(4):431-6. PubMed ID: 8485024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents.
    Manda VK; Avula B; Chittiboyina AG; Khan IA; Walker LA; Khan SI
    Xenobiotica; 2016; 46(2):117-25. PubMed ID: 26247834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.